-
921
Updates in Biliary Atresia: Aetiology, Diagnosis and Surgery
Published 2025-01-01“…Affected infants present with a triad of conjugated jaundice, pale stools, and dark urine and may have hepatosplenomegaly upon examination, with later ascites coincident with the onset of progressive liver disease. Rapid, efficient, and expeditious diagnosis is essential with the initial treatment being surgical, typically with an attempt to restore the bile flow (Kasai portoenterostomy (KPE)) or primary liver transplantation (<5%) if considered futile. …”
Get full text
Article -
922
Noninvasive Evaluation of Liver Fibrosis in a Sample of Putative Inactive HBV Carriers in Rome, Italy
Published 2021-01-01“…To investigate the risk of progression of the liver disease, liver stiffness (LS) and HBV-DNA were monitored over time. …”
Get full text
Article -
923
Five-Year Prospective Follow-Up of Patients with Hepatitis C Virus Infection Treated with Direct-Acting Antiviral Agents
Published 2025-01-01“…This research monitored occurrences of virological relapse, hepatocellular carcinoma (HCC), mortality, and liver disease progression. The annualized incidence rates (AIRs), cumulative incidence rates of adverse events and risk factors were investigated. …”
Get full text
Article -
924
Effects of pesticide dichlorvos on liver injury in rats and related toxicity mechanisms
Published 2025-01-01“…Recent epidemiological studies suggest that exposure to DDVP correlates with an increased incidence of liver disease. However, data regarding the hepatotoxicity of DDVP remain limited. …”
Get full text
Article -
925
Holotranscobalamin Is a Useful Marker of Vitamin B12 Deficiency in Alcoholics
Published 2012-01-01“…Falsely increased values of Cbl can be caused by alcoholic liver disease. Measurement of total vitamin B12 serum levels might be misleading in alcoholics, because a tissue metabolic deficiency is possible even with normal serum Cbl levels. …”
Get full text
Article -
926
Autoimmune hepatitis: new in diagnostics, a pathogenesis and treatment
Published 2012-09-01“…AIH is a chronic inflammatory liver disease which is characterized by destruction of terminal plate by mononuclear infiltrate (interface hepatitis) according to histological investigation, hypergammaglobulinemia and production of autoantibodies. …”
Get full text
Article -
927
The Role of Genetic and Immune Factors for the Pathogenesis of Primary Sclerosing Cholangitis in Childhood
Published 2016-01-01“…Primary sclerosing cholangitis (PSC) is a rare cholestatic liver disease characterized by chronic inflammation of the biliary tree resulting in liver fibrosis. …”
Get full text
Article -
928
Wilson’s Disease: Diagnosis of Wilson’s Disease in Ethiopian Young Sisters
Published 2020-01-01“…Both siblings had visible ocular Kayser–Fleischer rings, low serum ceruloplasmin level and increased urinary copper content, ultrasound-evidenced cirrhotic liver disease, and axial T2-weighted MRI hyperintensities in basal ganglia, thalamus, and brainstem (midbrain and pons). …”
Get full text
Article -
929
Hepatocellular Carcinoma with Both Fibrolamellar and Classical Components: An Unusual Morphological Pattern
Published 2015-01-01“…It is usually seen in young adults without underlying liver disease. Histologically, it shows large cells with abundant eosinophilic cytoplasm, large vesicular nuclei, prominent nucleoli, and lamellar type fibrosis. …”
Get full text
Article -
930
Effects of natural products on macrophage immunometabolism: A new frontier in the treatment of metabolic diseases
Published 2025-03-01“…Dysregulation of macrophage immunometabolism has been closely implicated in several metabolic diseases, including obesity, type 2 diabetes mellitus (T2DM), non-alcoholic fatty liver disease (NAFLD), hypertension, atherosclerosis, and gout, which positions macrophages as potential therapeutic targets. …”
Get full text
Article -
931
Meteorin-like alleviates hepatic steatosis by regulating hepatic triglyceride secretion and fatty acid oxidation
Published 2025-02-01“…Summary: Amid a rising prevalence of non-alcoholic fatty liver disease (NAFLD), there is still an unmet need to better treat it. …”
Get full text
Article -
932
Energy Expenditure in Infants in Health and Disease
Published 1997-01-01“…In disease states with altered body composition, such as cystic fibrosis and end-stage liver disease, predictive equations markedly underestimate both energy and fluid requirements. …”
Get full text
Article -
933
A Case of Glycogenic Hepatopathy as a Complication of Poorly Controlled Type 1 Diabetes Mellitus
Published 2022-01-01“…This case report describes how patterns and trends of liver function tests provide important clues to the diagnosis of GH; how imaging modalities like ultrasonography, computerized tomography (CT) scan, and magnetic resonance imaging (MRI) scan could be used to differentiate GH from nonalcoholic fatty liver disease (NAFLD); and how the diagnosis of GH can be made without the need for invasive liver biopsy. …”
Get full text
Article -
934
Endoplasmic Reticulum Stress-Associated Lipid Droplet Formation and Type II Diabetes
Published 2012-01-01“…The excessive deposition of lipid droplets (LDs) in specialized cell types, such as adipocytes, hepatocytes, and macrophages, has been found as a hallmark in ER stress-associated metabolic diseases, including obesity, diabetes, fatty liver disease, and atherosclerosis. However, much work remains to be done in understanding the mechanism by which ER stress response regulates LD formation and the pathophysiologic role of ER stress-associated LD in metabolic disease. …”
Get full text
Article -
935
Liver Protective Effect of Fenofibrate in NASH/NAFLD Animal Models
Published 2022-01-01“…Nonalcoholic fatty liver disease (NAFLD) is initiated by excessive fat buildup in the liver, affecting around 35% of the world population. …”
Get full text
Article -
936
Improving Survival in Decompensated Cirrhosis
Published 2012-01-01“…Organ allocation is prioritized for the sickest patients based on Model for End Stage Liver Disease (MELD) score. In order to improve survival in patients with high MELD score it is imperative to preserve them in suitable condition till transplantation. …”
Get full text
Article -
937
An Update on Less Invasive and Endoscopic Techniques Mimicking the Effect of Bariatric Surgery
Published 2012-01-01“…Obesity (BMI 30–35 kg/m2) and its associated disorders such as type 2 diabetes, nonalcoholic fatty liver disease, and cardiovascular disease have reached pandemic proportions worldwide. …”
Get full text
Article -
938
The Tao of Hematopoietic Stem Cells: Toward a Unified Theory of Tissue Regeneration
Published 2002-01-01“…Preclinical amelioration of liver disease and myocardial infarcts by HSC-enriched bone marrow cell populations raises the possibility that HSC transplants have the potential to provide therapeutic benefit for a wide variety of diseases. …”
Get full text
Article -
939
Protective Effects of Celastrol on Diabetic Liver Injury via TLR4/MyD88/NF-κB Signaling Pathway in Type 2 Diabetic Rats
Published 2016-01-01“…We firstly found that celastrol treatment could delay the progression of diabetic liver disease in type 2 diabetic rats via inhibition of TLR4/MyD88/NF-κB signaling cascade pathways and its downstream inflammatory effectors.…”
Get full text
Article -
940
Mouse Models of Nonalcoholic Steatohepatitis: Head-to-Head Comparison of Dietary Models and Impact on Inflammation and Animal Welfare
Published 2020-01-01“…The WD represents a model of advanced-stage NASH, and the HFD60 is a strong model of nonalcoholic fatty liver disease (NAFLD) and metabolic syndrome. However, the CAFD should not be considered a NASH model.…”
Get full text
Article